Ajanta Pharma Ltd - AJANTA PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE031B01049
₹ 1,725.95 (-1.14%) icon11 Aug, 2023, 3:58:34 PM
Open
₹ 1,742.05
Prev. Close
₹ 1,745.90
Turnover(lac)
₹ 1,229.89
Day's High
₹ 1,757.40
Day's Low
₹ 1,692.45
52 Wk High
₹ 1,777.50
52 Wk Low
₹ 1,111.60
Book Value
₹ 269.96
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 22,113.93
P/E
35.58
EPS
48.42
Div. Yield
0.40

Ajanta Pharma Ltd Stock View

info icon
Edit Image
BUY
Target | 04 Aug, 2023 1,767.92 (2.43%)

Ajanta Pharma Limited is an India-based company, which is primarily involved in development, manufacturing and marketing of specialty pharmaceutical finished dosages. The Company’s marketing... Read More

Ajanta Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 8/11/2023 3:58:34 PM

    ₹ 1725.95 -19.95 -1.14
  • Open
  • ₹ 1,742.05
  • Prev. Close
  • ₹ 1,745.9
  • Turnover(Lac.)
  • ₹ 1,230
  • Day's High
  • ₹ 1,757.4
  • Day's Low
  • ₹ 1,692.45
  • 52 Week's High
  • ₹ 1,777.5
  • 52 Week's Low
  • ₹ 1,111.6
  • Book Value
  • ₹ 269.96
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 22,113.93
  • P/E
  • 35.58
  • EPS
  • 48.42
  • Divi. Yield
  • 0.4

Ajanta Pharma Ltd Corporate Actions

28 Jul , 2023

12:00 AM

Dividend

Dividend amount: 15
Announcement date: 28 Jul , 2023

View Details

28 Jul , 2023

12:00 AM

Dividend

Dividend amount: 10
Announcement date: 28 Jul , 2023

View Details

14 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2023

12:00 AM

29 May , 2023

12:00 AM

AGM

Announcement date: 29 May , 2023

View Details

27 Apr , 2023

12:00 AM

27 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Jan , 2023

12:00 AM

03 Nov , 2022

12:00 AM

Dividend

Dividend amount: 7
Announcement date: 03 Nov , 2022

View Details

21 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Oct , 2022

12:00 AM


Ajanta Pharma Ltd News and Update

Image not found
  • 11 August, 2023 |
  • 7:25 PM

Recommendation: Buy; Target price: Rs 3150

Article Image
  • IIFL News Service |
  • 11 August, 2023 |
  • 7:25 PM
Image not found
  • IIFL News Service |
  • 11 August, 2023 |
  • 7:25 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Ajanta Pharma Ltd SHAREHOLDING SNAPSHOT
14 August , 2023 | 07:59 AM

PROMOTER - TOTAL66.21%

Indian: 66.21%

Foreign: 0%

NON-PROMOTER - TOTAL 33.79%

Institutions: 26.00%

Non-Institutions: 7.78%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Ajanta Pharma Ltd FINANCIALS

Ajanta Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Ajanta Pharma Ltd

  • Mannalal B Agrawal
  • Chairman (Non-Executive)
  • Madhusudan B Agrawal
  • Vice Chairman
  • Yogesh Agrawal
  • Managing Director
  • Chandrakanth M Khetan
  • Independent Director
  • Gaurang Shah
  • Vice President & CS
  • Rajesh M Agrawal
  • Joint Managing Director
  • K H Viswanathan
  • Independent Director
  • Prabhakar Dalal
  • Independent Director
  • Anjana Grewal
  • Independent Director

Summary

Ajanta Pharma is a specialty pharmaceutical company primarily involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets. It has a well-diversified business model in terms of markets, therapies and products. It produces a comprehensive range of specialty products targeting different therapeutic segments.The companys business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia. In India, the Company has presence in high growth specialty segments of cardiology, dermatology, ophthalmology and pain management.In branded generic business in emerging markets in Asia and Africa, Ajanta Pharmas products cater to therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products. The companys institutional business comprises of supplies to various government bodies in India and supply of Anti-Malarial products under WHO approved programs in Africa.Ajanta Pharma operates 7 state-of-the-art manufacturing facilities in India and Mauritius. 2 of the facilities in India have been successfully approved by US FDA. The company has an advanced Research & Development Centre in Mumbai for finished formulations and Active... Read More


Reports by Ajanta Pharma Ltd


Reports by Ajanta Pharma Ltd

Company FAQ

No Record Found